Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies
Details
Publication Year 2023-12,Volume 44,Issue #12,Page 971-985
Journal Title
Trends in Immunology
Publication Type
Review
Abstract
Macrophages represent a key component of the tumor microenvironment (TME) and are largely associated with poor prognosis. Therapeutic targeting of macrophages has historically focused on inhibiting their recruitment or reprogramming their phenotype from a protumor (M2-like) to an antitumor (M1-like) one. Unfortunately, this approach has not provided clinical breakthroughs that have changed practice. Emerging studies utilizing single-cell RNA-sequencing (scRNA-seq) and spatial transcriptomics have improved our understanding of the ontogeny, phenotype, and functional plasticity of macrophages. Overlaying the wealth of current information regarding macrophage molecular subtypes and functions has also identified novel therapeutic vulnerabilities that might drive better control of tumor-associated macrophages (TAMs). Here, we discuss the functional profiling of macrophages and provide an update of novel macrophage-targeted therapies in development.
Keywords
Humans; *Neoplasms/therapy/pathology; Macrophages/pathology; Phenotype; Tumor Microenvironment; TAM function; macrophage polarization; macrophage-targeted therapy; tumour-associated macrophages
Department(s)
Laboratory Research
Open Access at Publisher's Site
https://doi.org/10.1016/j.it.2023.10.007
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-01-19 06:18:41
Last Modified: 2024-01-19 06:44:07

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙